FDA Considers Range of Measures to Enhance Safety of High-Risk Excipients
This article was originally published in The Gold Sheet
FDA eyes all high-risk excipients in response to DEG-tainted glycerin issue.
You may also be interested in...
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.